While the difference seen in knockout tumors was modest, our results are consistent with previous studies showing how XRCC4 knockdown in tumor cells leads to increased sensitivity to radiation or chemotherapy drugs such as cisplatin (59, 60). Here, XRCC4 is linked to neoplasm.